**Sir:** The article by Khan (July 2006, p. 21) and letter by Abbasi (January 2007, p. 25) in *International Psychiatry* unfortunately tend to overlook many positive aspects of mental healthcare and services in Pakistan. Some of their views seem to relate more specifically to experience in the private healthcare system or are based on a distant view and very little information about the current situation. Both seem to be genuine attempts to highlight the inadequacies in the system, but these are well known.

The statement in the letter by Abbasi about the *Journal of Pakistan Psychiatric Society* (*JPPS*) is an example of this and is factually incorrect. I would like to point out that *JPPS* is in regular publication and it is incorrect to say that the journal has not been produced since 2003. It restarted publication in 2005 and two volumes have been published since then.

The *JPPS* is available free (full text) on <http://www.jpps.com.pk>. It is indexed by WHO, EMRO Index and also in a number of regional and local indexes. The journal has played an important role in the continuing professional development of psychiatrists in the region, as well as helped to disseminate research findings. In fact, *JPPS* brought out a special issue devoted to the 2005 earthquake, the very subject of Abbasi's letter. Since restarting its publication, it has played an important role in promoting evidence-based medicine. I would request your readers to contribute to the journal.

Dr Saeed Farooq

Editor, JPPS (Journal of Pakistan Psychiatric Society), email

sfarooqlrh\@yahoo.com

**Sir:** Although the three linked articles on ethnopharmacology in the July 2007 issue of *International Psychiatry* were necessarily heavily biologically focused, I must take issue with the fact that culture and clinical relationship attracted such brief comment. It is not possible, let alone desirable, to reduce people to the biological functions of their brains. The development of tools for testing individual genotypes opens up interesting possibilities, but represents a dangerous distraction from the challenge of addressing the realities represented by the global burden of disease. According to the World Health Organization, low- and middle-income countries, which will represent 80% of the world's population by 2020, are expected to bear the brunt of the projected increase in the burden of mental illness. The acquisition of approval by Roche of its Amplichip by the USA and European Union, as David Skuse mentions in his introduction to the series of papers, is a distortion of this reality by the pharmaceutical industry. Addressing the needs of most of the 400 million people disabled by neuropsychiatric conditions globally cannot be done without challenging these priorities. Those interested in international psychiatry need to reach a clear consensus about their agenda.

A thorough understanding of the culture of a patient (or patient group a service is supporting) is of course an essential bedrock on which to build sensitive relationships. The dynamic nature of any relationship is central to its positive development. A clinician should gradually know a patient or community better with time, and service users also gain a greater understanding of the opinions and attitudes of clinicians and services as they access care. An attitude of sensitive response to needs and aspirations is an important way for trust to develop, even when the starting points have been far apart. This can be fostered with good service design and continuous constructive evaluation at the formative, process and outcome stages, so that a service remains responsive to its intended users. It is with this attitude at a personal clinical level and as a component in system design that we can move forward in our complex world and not see cultural diversity as an obstacle to delivering care.

In my experience of working as a British psychiatrist in Nigeria, I have often been impressed by my clients' ability simultaneously to hold some of the messages of orthodox psychiatry and more traditional ideas. Local service staff such as field workers are also very skilled at working through these issues. Sometimes emphases for treatment plans seem to be in conflict, but much more frequently a plan for moving forward that is mutually acceptable is reached through which all parties involved are enriched.

Julian Eaton MRCPsych

Mental Health Advisor, West Africa, CBM International National Coordination Office, PO Box 8451, Wuse, Abuja, Nigeria, email

julian_eaton\@cbm-westafrica.org

**Sir:** We read with interest the article by Kulhara & Avasthi on the teaching and training of psychiatry in India in the April issue of *International Psychiatry* (p. 31). We acknowledge the possible options suggested by the authors to overcome some of the difficulties faced in psychiatric training in India.

Mr Ramadoss, Minister of Health, India, in a recent media report highlighted the acute shortage of psychiatrists in India and stated that over 30 000 psychiatrists are required to serve a billion people, while there are only 3300 practising in the country. Currently there are a significant number of doctors of Indian origin who are undergoing basic and higher specialty psychiatric training in the UK.

Owing to changes in immigration policies by the Home Office (i.e. termination of permit-free training for international medical graduates), some trainees are currently experiencing difficulties in progressing and obtaining consultant-grade posts. Some of the doctors who have completed their membership examinations (MRCPsych) and some who have completed their higher specialty training (CCT) are considering a return to establish their psychiatric practice in India. Strong family commitments and a desire to contribute to training and the development of the specialty (as well as economic growth) in India have enhanced their willingness to return home. These highly qualified psychiatrists will be great assets to the country.

Owing to the high standards in training and assessment for the MRCPsych qualification, it has been recognised by the Royal Australian and New Zealand College of Psychiatrists and the Canadian Psychiatric Association. However, the MRCPsych qualification is currently not recognised by the Medical Council of India (MCI). Hence these doctors will be ineligible to work in a teaching hospital or even in the public health services. Given the acute need for qualified psychiatrists in India it is unfortunate that the available resources are not being utilised adequately.

In this context we would like to suggest that there should be collaboration between the Indian Psychiatric Society, the MCI and the Royal College of Psychiatrists to negotiate for the recognition of the MRCPsych qualification by the MCI. If this succeeds, it would be the first step in encouraging psychiatrists trained in the UK to return home.

Dr Sudheer T Lankappa,
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Dr Ritu Gupta
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and Dr Abhijeeth R. Shetty
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Academic Clinical Psychiatry, The Longley Centre, Sheffield S5 7JT, UK, email

s.lankappa\@sheffield.ac.uk
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Mental Health Unit, Rotherham General Hospital, Rotherham, UK

**Sir:** I read with interest the critical review by Kala & Kala on mental health legislation in contemporary India in the July issue of *International Psychiatry* (pp. 69--71). Kala & Kala mention various shortcomings in the Indian Mental Health Act 1987. As a psychiatrist who has worked in both India and the UK (and thus under the Mental Health Acts of both countries) I would like to draw attention to some other gaps which I feel are as important.

First, the Indian Act does not mention involuntary medication at all. Involuntary medication is not synonymous with involuntary admission. Both voluntary and involuntary patients could in principle insist on having only psychological interventions and refuse all psychotropic medication. The powers and duties of a psychiatrist in such cases remain undefined by the Act. The Act similarly omits mention of electroconvulsive therapy. In a wider sense, it is not clear whether involuntary admissions (admission under special circumstances, admission under reception order) give psychiatrists the right to treat patients against their will.

Second, the Act does not define the circumstances under which involuntary admissions are advisable. A psychiatrist and two medical practitioners agreeing that a patient has a mental illness and needs treatment is not enough. Treatment for psychiatric illnesses is also possible in the community. Where do we draw a line?

Third, the Act attempts to define 'psychiatrist' and 'medical practitioner' early in its text. It is not absolutely necessary to have a psychiatric postgraduate qualification to be deemed a 'psychiatrist' under the Act. A medical practitioner with sufficient experience in psychiatry can also be considered a 'psychiatrist' for the purposes of the Act. What constitutes sufficient 'experience' for the purposes of the Act again remains undefined.

Fourth, the Act does not include prescribed forms for involuntary admissions. Without prescribed forms, any kind of uniform, standardised practice throughout a country with dimensions such as India will remain difficult to implement.

Fifth, the Act does not mention the role of psychiatrists in the case of prisoners who are mentally ill. They are a large population who remain for the most part neglected by both the criminal justice system and the health services in India. In my experience, psychiatrists are involved only to the extent of giving reports about whether a person is 'fit to stand trial'. While working in India, I often wondered what happened to prisoners who became mentally ill in prison, or people who were not convicted after making a successful insanity plea but remained dangerous to society because of their psychopathology.

India's resources are limited but that is no excuse to stop planning, to look for what remains missing in this vital piece of legislation. Unless we plan, we do not know what kind of resources we need or whether we can modify and use an existing infrastructure. It is time to act.

Nandini Chakraborty MD DNB MRCPsych

Staff Grade in Forensic Psychiatry, Arnold Lodge, Leicester, email

Nandini.Chakraborty\@nottshc.nhs.uk

**Sir:** Working conditions can have a dramatic impact on the training of psychiatrists. We write about the stark contrast between those in Russia and the UK.

Working conditions for doctors in Russia have deteriorated since the collapse of the USSR. Healthcare in the state sector is free for patients but under-funded. Psychiatrists continue to work under the burden of a huge degree of stigma, both from within the medical profession and from the general public. This stems from the abuse of psychiatry in the former USSR for political purposes.

Psychiatrists in Russia earn much less than those in the UK. Trainees working in a state institution earn approximately €70 a month (£50), compared with between £2000 and £3000 a month for trainees in the UK. A Russian psychiatrist working in the state sector who has been qualified for 5 years and works extra night shifts earns €150 a month (£100). Salaries in the private sector are much higher, with a professor earning between €2000 and €3000 (£1350-- £2000), although this is still less than a trainee in the UK. Some psychiatrists in Russia earn less than non-professional workers; for example, security guards earn around €500 a month (£350). Although the wages are substantially lower than in the UK, the cost of living is similar. A month's rent for a single-room apartment in Moscow is on average €800 (£550), which is comparable to London prices. Clearly, this makes it impossible for trainees to survive on their salary and the co-author personally knows many who are supported by their families and work extra shifts and have second jobs. It is not uncommon for patients and relatives who recognise the poor working conditions to offer doctors money to thank them for good care and treatment.

In Russia, psychiatric training lasts for up to 3 years (1 year of internature and 2 years of ordinature), compared with the 6 years of the new run-through training in the UK. In contrast to the current concerns in the UK over the number of training posts, there are plenty of posts for psychiatric trainees in Russia. This is because it is not a popular job, owing to the low salary, and for the same reason there are many specialist jobs available when training is complete. Other medical specialties, such as obstetrics and dermatology, are more popular and better paid.

Trainees in Russia have shorter working hours than their colleagues in the UK. They work approximately 40 hours a week compared with up to 56 hours a week in the UK. They are also entitled to more annual leave, nearly 2 months compared with 5 weeks in the UK.

We hope that increasing cooperation between European psychiatric associations will lead to an improvement in both training and working conditions for psychiatrists in Russia.

Clare Oakley MB ChB MRCPsych
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Senior House Officer, Birmingham and Solihull Mental Health Trust, Lyndon Clinic, Hobs Meadow, Solihull, West Midlands, B92 8PW, UK, email

clareoakley\@doctors.org.uk
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Psychiatric trainee, Moscow Research Institute of Psychiatry, 3 Poteshnaja Street, Moscow, Russia, email

nazaralieva\@gmail.com
